definiens: means, with respect to a Licensed Product that ha s received Marketing Approval in a country in the Territory, ( a ) a biologic therapeuti c containing the same amino acid polymer as any Lic ensed Product ; ( b ) a biologic therapeutic containing an a mino acid polymer that is highly similar, or simila r enough to one contained in a reference Licensed Product, notw ithstanding minor differences in clinically inactiv e components, to permit an applicant for Regulatory A pproval for such biologic therapeutic to refer to a nd rely on clinical and other scientific Information regarding the safety, purity, potency and/or efficacy of the reference Licensed Product in order to allow such biologic th erapeutic to receive Regulatory Approval in any jur isdiction within the Territory through an abbreviated regulat ory pathway ; or ( c ) a biologic therapeutic containi ng an amino acid polymer that is highly similar, or similar eno ugh to one contained in a reference Product, notwit hstanding minor differences in clinically inactive components, to permit such biologic therapeutic to be markete d in any jurisdiction within the Territory as generic - equiva lent, functionally equivalent, biosimilar, biogener ic, biobetter, interchangeable, or by using any other description referring to the reference Product ( and/or such Pro duct ’s clinical and other scientific Information ) for support for s afety, purity, potency and/or efficacy claims for s uch biologic therapeutic